{"cdcTestId":"2016-0017","testcaseName":"Adolescent child age 15 with one dose of the HPV vaccine","vaccineGroup":"HPV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2007-05-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Gardasil 9","cvx":"165","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-16T00:00:00","pastDueDate":"2023-02-07T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Gardasil 9","cvx":"165","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2016-12-02T00:00:00","dateUpdated":"2020-06-15T09:09:35.826","generalDescription":"This test case describes when an adolescent child age 15 years has been administered the first dose of the HPV vaccine that another dose should be forecast.","changedInVersion":"3.4","reasonForChange":"v3.4: Earliest Recommended Date was changed from 8 weeks to 4 weeks on Dose 2 per HPV MMWR language."}